184 related articles for article (PubMed ID: 15905359)
21. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
[TBL] [Abstract][Full Text] [Related]
22. [Structure-activity relationship of ghrelin].
Minamitake Y
Nihon Rinsho; 2004 Sep; 62 Suppl 9():328-31. PubMed ID: 15506395
[No Abstract] [Full Text] [Related]
23. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.
Patchett AA; Nargund RP; Tata JR; Chen MH; Barakat KJ; Johnston DB; Cheng K; Chan WW; Butler B; Hickey G
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7001-5. PubMed ID: 7624358
[TBL] [Abstract][Full Text] [Related]
24. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor.
Thompson NM; Gill DA; Davies R; Loveridge N; Houston PA; Robinson IC; Wells T
Endocrinology; 2004 Jan; 145(1):234-42. PubMed ID: 14551228
[TBL] [Abstract][Full Text] [Related]
25. Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging.
Smith RG; Sun Y; Jiang H; Albarran-Zeckler R; Timchenko N
Ann N Y Acad Sci; 2007 Nov; 1119():147-64. PubMed ID: 18056963
[TBL] [Abstract][Full Text] [Related]
26. Identification of the atypical L-type Ca2+ channel blocker diltiazem and its metabolites as ghrelin receptor agonists.
Ma JN; Schiffer HH; Knapp AE; Wang J; Wong KK; Currier EA; Owens M; Nash NR; Gardell LR; Brann MR; Olsson R; Burstein ES
Mol Pharmacol; 2007 Aug; 72(2):380-6. PubMed ID: 17475811
[TBL] [Abstract][Full Text] [Related]
27. Over-expression of the truncated ghrelin receptor polypeptide attenuates the constitutive activation of phosphatidylinositol-specific phospholipase C by ghrelin receptors but has no effect on ghrelin-stimulated extracellular signal-regulated kinase 1/2 activity.
Chu KM; Chow KB; Leung PK; Lau PN; Chan CB; Cheng CH; Wise H
Int J Biochem Cell Biol; 2007; 39(4):752-64. PubMed ID: 17169600
[TBL] [Abstract][Full Text] [Related]
28. Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators.
Berizzi AE; Gentry PR; Rueda P; Den Hoedt S; Sexton PM; Langmead CJ; Christopoulos A
Mol Pharmacol; 2016 Oct; 90(4):427-36. PubMed ID: 27461343
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men.
Laferrère B; Abraham C; Russell CD; Bowers CY
J Clin Endocrinol Metab; 2005 Feb; 90(2):611-4. PubMed ID: 15699539
[TBL] [Abstract][Full Text] [Related]
30. Interaction of the growth hormone-releasing peptides ghrelin and growth hormone-releasing peptide-6 with the motilin receptor in the rabbit gastric antrum.
Depoortere I; Thijs T; Thielemans L; Robberecht P; Peeters TL
J Pharmacol Exp Ther; 2003 May; 305(2):660-7. PubMed ID: 12606621
[TBL] [Abstract][Full Text] [Related]
31. Signal transduction mechanism of the seabream growth hormone secretagogue receptor.
Chan CB; Leung PK; Wise H; Cheng CH
FEBS Lett; 2004 Nov; 577(1-2):147-53. PubMed ID: 15527776
[TBL] [Abstract][Full Text] [Related]
32. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells.
Ghè C; Cassoni P; Catapano F; Marrocco T; Deghenghi R; Ghigo E; Muccioli G; Papotti M
Endocrinology; 2002 Feb; 143(2):484-91. PubMed ID: 11796502
[TBL] [Abstract][Full Text] [Related]
33. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats.
Granado M; Priego T; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E486-92. PubMed ID: 15507538
[TBL] [Abstract][Full Text] [Related]
34. Ghrelin: endocrine and non-endocrine actions.
Broglio F; Arvat E; Benso A; Papotti M; Muccioli G; Deghenghi R; Ghigo E
J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1219-27. PubMed ID: 12510973
[TBL] [Abstract][Full Text] [Related]
35. A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429).
Schoen WR; Pisano JM; Prendergast K; Wyvratt MJ; Fisher MH; Cheng K; Chan WW; Butler B; Smith RG; Ball RG
J Med Chem; 1994 Apr; 37(7):897-906. PubMed ID: 8151616
[TBL] [Abstract][Full Text] [Related]
36. [Ghrelin-related drugs: clinical perspectives].
Shimatsu A
Nihon Rinsho; 2004 Sep; 62 Suppl 9():435-8. PubMed ID: 15506422
[No Abstract] [Full Text] [Related]
37. Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes.
Malagón MM; Luque RM; Ruiz-Guerrero E; Rodríguez-Pacheco F; García-Navarro S; Casanueva FF; Gracia-Navarro F; Castaño JP
Endocrinology; 2003 Dec; 144(12):5372-80. PubMed ID: 12960033
[TBL] [Abstract][Full Text] [Related]
38. Highly potent growth hormone secretagogues: hybrids of NN703 and ipamorelin.
Hansen TK; Ankersen M; Raun K; Hansen BS
Bioorg Med Chem Lett; 2001 Jul; 11(14):1915-8. PubMed ID: 11459660
[TBL] [Abstract][Full Text] [Related]
39. Hormone fatty acid modifications: gram negative bacteria and vertebrates demonstrate common structure and function.
Tizzano M; Sbarbati A
Med Hypotheses; 2006; 67(3):513-6. PubMed ID: 16644138
[TBL] [Abstract][Full Text] [Related]
40. Effects of growth hormone secretagogues on the release of adenohypophyseal hormones in young and old healthy dogs.
Bhatti SF; Duchateau L; Van Ham LM; De Vliegher SP; Mol JA; Rijnberk A; Kooistra HS
Vet J; 2006 Nov; 172(3):515-25. PubMed ID: 15951209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
